-
Innovation Ranking
Innovation Ranking - Mallinckrodt Plc
Mallinckrodt Plc (Mallinckrodt) develops, produces, markets, and distributes specialty pharmaceutical products and therapies. The company offers branded pharmaceutical products for autoimmune and rare diseases in specialty areas such as rheumatology, nephrology, neurology, pulmonology and ophthalmology. It also offers immunotherapy, oncology and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. It offers specialty generic drugs and active pharmaceutical ingredients. Mallinckrodt markets branded products directly to physicians, specialty pharmacies, hospitals and ambulatory surgical centers; and also distributes branded and generic products...
-
Innovation Ranking
Innovation Ranking - ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc (ANI) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals. The company offers pharmaceuticals for central nervous system (CNS) disorders, gastrointestinal, cancer, ophthalmic, metabolic and other diseases. ANI also conducts business as a Contract Development and Manufacturing Organization (CDMO) supporting late-stage development to commercial manufacture of pharmaceutical products including coated/non-coated tablets and capsules, ointments, creams, non-sterile liquids, suspensions, and gels. It markets oncology products, complex formulations, hormones and steroids and controlled...
-
Innovation Ranking
Innovation Ranking - Nektar Therapeutics
Nektar Therapeutics (Nektar) discovers and develops novel therapeutic drug candidates based on its PEGylation and advanced polymer conjugate technology platforms to address unmet medical needs. The company’s technology platforms offer a wide range of functional attributes, which optimizes and enhances the profile of a wide range of molecules including large classes of drugs targeting numerous disease areas. The company’s products focus on various disease areas including cancer, pain, infections, and immunology among others. Its research and development involve peptides, proteins,...
-
Innovation Ranking
Innovation Ranking - Argenx SE
Argenx SE (argenx) is an immunology company that focuses on the development of human antibodies. The company is primarily developing products for autoimmune diseases. Its key product includes VYVGART, a neonatal Fc receptor blocker, which is used to treat generalized myasthenia gravis in adults which are anti-acetylcholine receptor (AChR) antibody positive. The company’s pipeline products include Efgartigimod, ARGX-117, Cusatuzumab, ARGX-118, ARGX-119 and ARGX-120. argenx in partnership with Leo Pharma, AgoMab, AbbVie and Staten has been licensed to develop products such...
-
Innovation Ranking
Innovation Ranking - UroGen Pharma Ltd
UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd, is a biopharmaceutical company that develops novel medicines to treat cancer indications and urologic diseases. The company products include Jelmyto is a drug formulation of mitomycin used to treat low-grade upper tract urothelial cancer. Its pipeline products include UGN-102 is a mitomycin gel is used to treat low-grade intermediate risk non-muscle invasive bladder cancer; UGN-201 and UGN-302 targets high-grade non-muscle invasive bladder cancer and Botox or RTgel for the treatment of overactive...
-
Innovation Ranking
Innovation Ranking - Taro Pharmaceutical Industries Ltd
Taro Pharmaceutical Industries Ltd (Taro) discovers, develops and markets healthcare products. The company manufactures prescription drugs, non-prescription drugs and active pharmaceutical ingredients (APIs). It develops pharmaceutical products in semi-solids formulations, such as ointments and creams and other dosage forms including liquids, capsules and tablets. Taro develops products in dermatological and topical, neuropsychiatric, anti-inflammatory and cardiovascular areas. The company sells and distributes its product to healthcare institutions, drug store chains, and private pharmacies. It has presence in Israel, the US, Canada...
-
Innovation Ranking
Innovation Ranking - Shin Poong Pharm Co Ltd
Shin Poong Pharm Co Ltd (Shin Poong) is a pharmaceutical company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. Its product portfolio includes over-the-counter, cephalosporin, penicillin, gentrisone cream, tolvaptan, mosapride citrate, medical devices, pyramax, irbesartan, and praziquantel. Shin Poong develops medicines in tablets, capsules, injections, syrups, ampoules, and creams. The company manufactures products for treating malaria, cardiovascular, and bone-related diseases. It operates in Gyeonggi-do, Ansan-si, Banweol and Chungbuk-do, South Korea. Shin Poong is headquartered in Seoul, South Korea.
-
Innovation Ranking
Innovation Ranking - Joincare Pharmaceutical Group Industry Co Ltd
Joincare Pharmaceutical Group Industry Co Ltd (Joincare Pharma) develops, manufactures, and supplies pharmaceutical products. The company offers products such as health products, prescription drugs, inhalation preparation, and others. The company operates through chemical and detection reagents, traditional Chinese medicine, health products, chemical API, and monoclonal antibody business segments. The company provides API(Active Pharmaceutical Ingredient) such as cephalosporin series, statin series, carbapenem series, and some other others of APIs. Joincare Pharma is headquartered in Shenzhen, China.
-
Innovation Ranking
Innovation Ranking - AstraZeneca Plc
AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company, which is focused on discovery, production and commercialization of a range of prescription drugs. It develops products related to therapy areas such as respiratory, cardiovascular, renal and metabolic diseases, cancer, autoimmune, infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly- owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The...
-
Innovation Ranking
Innovation Ranking - Zealand Pharma AS
Zealand Pharma AS (Zealand) is a biotechnology company. It discovers, designs and develops peptide-based medicines that target specialty diseases. The company's product portfolio comprises glepaglutide which is a long-acting GLP-2 analog in development for the treatment of short bowel syndrome and dasiglucagon is used against type 1 diabetes and congenital hyperinsulinism. It also offers GLP1-GLU which is used against several cardio-metabolic diseases such as heart disease, ischemic stroke and liver diseases. Zealand conducts research and development and in-licensing programs. It...